The 2020 Joint Research Project Call for Proposals between DOST and the Ministry of Science and Technology (MOST) of the People’s Republic of China is now open!

In pursuit of cooperation between the Department of Science and Technology (DOST) and the Ministry of Science and Technology (MOST) of the People’s Republic of China, we are calling for mutually beneficial and collaborative project proposals in any of the following identified priority areas:

  1. Health
  2. Agriculture
  3. Renewable Energy

A total of eight (08) new projects will be approved during this call for proposals. DOST will provide an annual funding of up to Php 8,000,000.00 for each approved research project, while MOST will provide an annual funding of up to RMB 1,000,000.00 for the Chinese counterpart. Each project should have a maximum duration of two (2) years.

For reference, below is the timeline for the 2020 DOST-MOST JRP Call for Proposals: 

TIMELINE

Deadline for submitting applications:

26 June 2020

 

Exchange lists of applications that meet the eligibility requirements:

By the end of June 2020

 

Exchange of respective review results:

By the end of September 2020

Selection decision and announcement:

By the end of October 2020

Start of project:

From January 2021 to December 2022

Submission of final reports:

Upon completion of each project

 

Interested parties are advised to coordinate with prospective counterpart/collaborator in China to craft the project proposals. The Filipino researcher must submit the capsule proposal to DOST through the Office of the Assistant Secretary for International Cooperation while the Chinese counterpart will submit the same to MOST for separate review and evaluation. Only proposals that are endorsed for further submission of full-blown proposals will undergo technical review and possible approval by both DOST and MOST.

The necessary DOST-GIA forms may be downloaded at http://tiny.cc/DOSTGIAForms. For further inquiries, you may contact Ms. Andrea Velasquez of the Office of the Assistant Secretary for International Cooperation, at Tel. No.: +632-8-838-8376 or email at This email address is being protected from spambots. You need JavaScript enabled to view it. /This email address is being protected from spambots. You need JavaScript enabled to view it..

Call for Research Proposals: AHEAD-HPSR Program


The Department of Health (DOH) and the Philippine Council for Health Research and Development (PCHRD) is pleased to announce the first call for research proposals for the Advancing Health through Evidence-Assisted Decisions with Health Policy and Systems Research (AHEAD-HPSR) Program.

Interested institutions, organizations, and researchers are invited to submit a full proposal on any of the topics listed below.


1. Review of Innovative Health Financing for NCDs among ASEAN Member States
2. Assessment of Indoor Air Quality in Philippine Public Conveyances During Electronic Cigarette and Tobacco Heating System Use
3. Impact Assessment On The Implementation Of Value Added Tax (VAT) Exemption To Medicines Prescribed For Diabetes, Hypertension And High Cholesterol
4. A Situational Analysis on the Drug Shortages and Stock-outs in the Philippines: Causes, Frequency, Impact and Management Strategies
5. Assessing The Philippine Emergency Obstetrics And Newborn Care (EmONC) Initiative
6. Development Of Standard Method For Estimation Of Hospital Acquired Infection (HAI) Rate
7. Implementation of Province/City-Wide Workload Indicators of Staffing Needs (WISN) Study in Select Universal Health Care Integration Sites (UIS)
8. Market Mapping and Landscape Analysis of the Novel Tobacco Product Industry in the Philippines
9. Health Facilities And Services Regulatory Bureau’s Reform Roadmap
10. Development Of A Comprehensive Social And Behavior Change (SBC) Plan For Primary Care In The Philippines


Interested institutions, organizations, and researchers are invited to submit a full proposal on any of the topics hereto attached.


Kindly submit your proposal and the following requirements on or before May 15, 2020 to Ms. Guidita L. Gelera at This email address is being protected from spambots. You need JavaScript enabled to view it. or Ms. Clarissa B. Reyes at This email address is being protected from spambots. You need JavaScript enabled to view it.

  1. Letter of Intent
  2. Project Proposal following the PCHRD Detailed Proposal Form
  3. Workplan Schedule (Gantt Chart of Activities)
  4. Proposed Line-Item Budget (LIB)
  5. Informed Consent Form (for studies involving human subjects)
  6. Curriculum Vitae of lead proponent (Principal Investigator/Project Leader)
  7. Duties and Responsibilities of each project personnel
  8. Profile of the institution
  9. Endorsement of agency head

For queries, you may contact Ms. Clarissa B. Reyes.

The public can now access latest updates on coronavirus research, news, library resources, and other related information in one site through the COVID-19 CORe (Communication, Ongoing projects, Research) Portal developed and managed by the Department of Science and Technology-Philippine Council for Health Research and Development (DOST-PCHRD).

Aiming to strengthen the country’s pandemic information dissemination efforts, DOST-PCHRD compiles all available evidence-based information on COVID-19, including local and international research, local innovations, pandemic analysis and policy papers, webinars, and local healthcare facilities.

http://covid19.healthresearch.ph/

The portal also provides access to COVID-19 trackers and useful links to official advisories and recognized library resources of various health organizations and the academe such as the World Health Organization, John Hopkins Libraries, and the University of the Philippines (UP). 

“We need to boost the generation of solutions against the coronavirus pandemic, and building an open-access portal to related resources will aid our researchers and the public with legitimate and evidence-based information on COVID-19, ” said Dr. Jaime C. Montoya, Executive Director of DOST PCHRD.

DOST-PCHRD expects to add resources to the portal as more information becomes available to the public. The portal is free and can be easily accessed at  http://covid19.healthresearch.ph/. Meanwhile, the Council is also managing HERDIN Plus (www.herdin.ph), an online portal that provides easy management and access to health research and related information.

Project Title: SOLIDARITY Treatment Trial: Multicenter Randomized Trial of Additional Treatments for COVID-19 in Hospitalized Patients

Project Leader:
Marissa M. Alejandria, MD, MSc
Implementing Agency: National Institutes of Health- University of the Philippines Manila
Duration: 12 months


Project Description:

Despite worldwide efforts to develop a treatment against COVID-19, there is still no evidence-based medication proven effective to fight the virus.

To compare the effects of major COVID-19 treatment outcomes among hospitals globally, the World Health Organization (WHO) organized a solidarity treatment trial aimed at unifying efforts to assess any effects and provide reliable estimates of these treatments on COVID-19 cases. As one of the participating countries, the Philippines is conducting a study among 24 hospitals from Luzon, Visayas, and Mindanao. The study will test the safety and effectiveness of four repurposed drugs in treating COVID-19 compared to the standard of care being practiced in all participating hospitals.

The project is expected to provide evidence-based clinical practice guidelines for the care of COVID-19 patients and, eventually, provide evidence-based medicine against the virus. Funded by the Department of Science and Technology through the Philippine Council for Health Research and Development (DOST-PCHRD), the project has been approved for implementation last April 11, 2020 and has started enrolling patients.

Budgetary Requirement: Php 30 million

As the cases of the novel coronavirus in the country continue to rise, the Department of Health (DOH) seeks for additional medical equipment such as ventilators and respirators to help severely ill COVID-19 patients confined in intensive care unit (ICU).

To answer this call, a research team consisting of pulmonologists and biomedical engineers, led by Dr. Abundio Balgos of UP Manila, developed GINHAWA, a compact, safe and effective ventilator that can be used for both children and adults. The project started in 2012, in collaboration with biomedical engineers from De La Salle University and then proceeded with the redesign phase in 2019 with the help of biomedical technicians led by Mr. Glenn Tuazon. 

GINHAWA costs 42 percent cheaper than similar portable ventilators intended for use in ICUs, emergency rooms and ambulances. The technology has an embedded software protocol for self-diagnosis, protocol for cloud-assisted troubleshooting, repair and patient data analytics. 

To date, bench testing using Michigan Instruments Pneuview Test Lung and animal studies testing were done, proving its safety and efficacy. Initial human trials were also conducted, with six patients included in the human safety and efficacy studies.

The locally-developed GINHAWA is made possible through funding support from the Department of Science and Technology-Philippine Council for Health Research and Development (DOST-PCHRD).

For more locally-developed technologies on COVID-19, visit http://www.pchrd.dost.gov.ph/